OTCMKTS:MCVEF Medicover AB (publ) (MCVEF) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free MCVEF Stock Alerts $12.25 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$12.25▼$12.2550-Day Range$11.26▼$12.2552-Week Range$12.25▼$12.25VolumeN/AAverage Volume3,375 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Medicover AB (publ) alerts: Email Address Ad Stansberry Research$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).Find out how to do right here in this free video. About Medicover AB (publ) Stock (OTCMKTS:MCVEF)Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.Read More MCVEF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MCVEF Stock News HeadlinesApril 29, 2024 | americanbankingnews.comMedicover AB (publ) (OTCMKTS:MCVEF) Sees Significant Drop in Short InterestApril 24, 2024 | americanbankingnews.comMedicover AB (publ) (OTCMKTS:MCVEF) Trading 8.8% Higher May 3, 2024 | Stansberry Research (Ad)The Long-Awaited End of America UpdateA 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it.February 23, 2024 | fool.comCalliditas Therapeutics Ab (publ) (NASDAQ: CALT)January 17, 2024 | morningstar.comMedicover AB Class B MCOVBsDecember 1, 2023 | morningstar.comMedicover AB Class B MCOV BNovember 6, 2023 | finance.yahoo.comMedicover AB: Issue and repurchase of class C shares for incentive programNovember 3, 2023 | finance.yahoo.comJoe Ryan to retire as Medicover Chief Financial Officer in 2024May 3, 2024 | Stansberry Research (Ad)The Long-Awaited End of America UpdateA 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it.July 26, 2023 | finance.yahoo.comMedicover Interim report April-June 2023July 21, 2023 | wsj.comMedicover AB Series BJuly 20, 2023 | finance.yahoo.comMedicover continue to expand the dental network in GermanyJuly 20, 2023 | finance.yahoo.comMedicover Interim report July-September 2022July 20, 2023 | finance.yahoo.comMedicover: Year-end report January-December 2022July 20, 2023 | finance.yahoo.comMedicover: Interim report January-March 2023July 20, 2023 | finance.yahoo.comBulletin from annual general meeting in Medicover AB (publ)See More Headlines Receive MCVEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicover AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:MCVEF CUSIPN/A CIKN/A Webwww.medicover.com Phone46.8.400.17.600FaxN/AEmployees45,316Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Fredrik Rågmark (Age 61)CEO & Director Comp: $1.1MMr. Joe Ryan (Age 59)Chief Financial Officer Mr. Jaroslaw Urbanczyk (Age 56)Chief Information Officer Hanna BjellquistHead of Investor RelationsMs. Jenny Brandt (Age 50)General Legal Counsel Dr. Andrew Vallance-Owen FRCS Ed (Age 73)MBA, Chief Marketing Officer Ms. Kamila SkorupinskiGroup Chief People OfficerMr. John Paul Stubbington (Age 56)Chief Operating Officer of Healthcare Services Mr. Staffan Ternstrom (Age 59)Chief Operating Officer for Diagnostic Services More ExecutivesKey CompetitorsAmerican Oncology NetworkNASDAQ:AONCWAmerican Oncology NetworkNASDAQ:AONCBangkok Dusit Medical Services PublicOTCMKTS:BDULFBumrungrad Hospital PublicOTCMKTS:BUHPFCareRxOTCMKTS:CHHHFView All Competitors MCVEF Stock Analysis - Frequently Asked Questions How have MCVEF shares performed in 2024? Medicover AB (publ)'s stock was trading at $11.26 at the beginning of the year. Since then, MCVEF stock has increased by 8.8% and is now trading at $12.25. View the best growth stocks for 2024 here. Are investors shorting Medicover AB (publ)? Medicover AB (publ) saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 78,700 shares, a drop of 15.3% from the March 31st total of 92,900 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days. View Medicover AB (publ)'s Short Interest. How do I buy shares of Medicover AB (publ)? Shares of MCVEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MCVEF) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicover AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
